Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma
Clinical trial NCT02839720 · COMPLETED
Trial details
- NCT number
- NCT02839720
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-26
- Primary completion
- 2022-11-05
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.